发明名称 |
Calcium-independent phospholipase A2 induces ischemic ventricular arrhythmias and decreases infarction size |
摘要 |
A method for evaluating a compound to determine the relative or absolute therapeutic capability of a compound to pharmacologically inhibit ischemia induced activation of iPLA<SUB>2</SUB>beta in an intact myocardium which comprises treating intact myocardium with a compound, inducing ischemia in the myocardium tissue and determining if there has been a change in expression of iPLA<SUB>2</SUB>beta, its activity or in the iPLA<SUB>2</SUB>beta regulating network and determining if there has been a change then that the compound is an anti-arrhythmia or myocardial salvage drug.
|
申请公布号 |
US7195888(B2) |
申请公布日期 |
2007.03.27 |
申请号 |
US20030737167 |
申请日期 |
2003.12.15 |
申请人 |
WASHINGTON UNIVERSITY IN ST. LOUIS |
发明人 |
GROSS RICHARD W. |
分类号 |
C12Q1/34;A01K67/027;A61B;C07H21/04;C12N9/16;C12N9/20;C12Q1/44;G01N33/50;G01N33/92 |
主分类号 |
C12Q1/34 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|